Surgery for focal cortical dysplasia in drug-resistant epilepsy: case report and literature review
DOI:
https://doi.org/10.59156/revista.v39i01.583Keywords:
Drug-resistant epilepsy, Epilepsy surgery, Focal cortical dysplasia, Indications for surgery in epilepsyAbstract
Background: therapeutic gestures concerning drug-resistant epilepsy provide a scenario where the role of surgery has had a great contribution in recent decades in terms of objectives to be achieved, which are not limited to the complete cessation of seizures but also include the so-called “palliative goal” (conversion to non-refractory epilepsy, reduction of antiepileptic drugs and number of seizures).
Objectives: to optimize the diffusion of the pathology and promote early referrals to improve surgical results.
Case description: case 1: patient aged 27 years, 5 seizures per week (10 seconds duration), MRI: right frontal lesion hypointense on T1, hyperintense on T2, 3 x 2.25 x 2.84 cm. Case 2: patient aged 60 years, 2-3 seizures per day every 5-8 days (10 minutes duration), MRI: right hippocampal-amygdala lesion hypointense on T1, hyperintense on T2, 2.7 x 2.5 x 1.3 cm.
Surgery: case 1: right hemicoronal approach, using electrocorticography complete excision of the lesion was performed without residual epileptogenic tissue. Case 2: right frontotemporal approach with temporal polectomy plus right amygdalohippocampectomy.
Conclusion: surgical treatment for epilepsy has undergone a permanent evolution based on a greater understanding of the pathology and advances in imaging techniques. The outlook is encouraging, but there are still delays in referral to a surgical specialist.
Downloads
References
Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med, 2000; 342(5): 314-9. Doi: https://doi.org/10.1056/nejm200002033420503.
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Hauser WA, Mathern G, et al. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 2010; 51(6): 1069-77. Doi: https://doi.org/10.1111/j.1528-1167.2009.02397.x.
Brodie MJ, Barry SJ, Bamagous GA, Norrie JD, Kwan P. Patterns of treatment response in newly diagnosed epilepsy. Neurology, 2012; 78(20): 1548-54. Doi: 10.1212/WNL.0b013e3182563b19.
Becker AJ, Blümcke I, Urbach H, Hans V, Majores M. Molecular neuropathology of epilepsy-associated glioneuronal malformations. J Neuropathol Exp Neurol, 2006; 65(2): 99-108. Doi: 10.1097/01.jnen.0000199570.19344.33.
Lerner JT, Salamon N, Hauptman JS, Velasco TR, Hemb M, Wu JY, et al. Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia, 2009; 50(6): 1310-35. Doi: 10.1111/j.1528-1167.2008.01998.x.
Taylor DC, Falconer MA, Bruton CJ, Corsellis JA. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry, 1971; 34(4): 369-87. Doi: 10.1136/jnnp.34.4.369.
Jehi L. The epileptogenic zone: concept and definition. Epilepsy Curr, 2018; 18(1): 12-6. Doi: 10.5698/1535-7597.18.1.12.
Pomata HB. Cirugía de la Epilepsia. Parte 1. Rev Argent Neuroc, 1999; 13(1-2). Disponible en: https://aanc.org.ar/ranc/items/show/791.
Engel J Jr. What can we do for people with drug-resistant epilepsy? The 2016 Wartenberg Lecture. Neurology, 2016; 87(23): 2483-9. Doi: 10.1212/WNL.0000000000003407.
